RxDoctor Payments Data

John Averette

Physician Assistant · Asheville, NCNPI 1689139768

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $26,775 of the $34,082 with a category attached, or 78.6%. AbbVie accounts for 93.8% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2023 at $28,025 and has fallen 98.5% since, to $413 in 2025. Among physician assistant clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$34,082in general payments, 2019–2025

Across 219 payments — averaging $155.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$32K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$530
  • Otsuka America Pharmaceutical, Inc.$393
  • Alkermes, Inc.$376
  • Vanda Pharmaceuticals Inc.$303
  • Teva Pharmaceuticals USA, Inc.$115
  • plus $398 from 6 others

What the payments were for

  • Speaking & faculty fees$26,77579%
  • Travel & lodging$3,81011%
  • Food & beverage$3,44210%
  • Education$550%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$34,082 in reported general payments places this provider in the 95th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl77$111,276
Invega SustennaPaliperidone Palmitate33$103,746
LybalviOlanzapine/Samidorphan Malate46$65,553
AristadaAripiprazole Lauroxil17$55,461
Abilify MaintenaAripiprazole14$43,442
SublocadeBuprenorphine11$22,208
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine44$3,118
Trazodone Hcl139$2,076
Gabapentin144$2,036
Olanzapine OdtOlanzapine22$1,857
Atomoxetine Hcl23$1,667
Lurasidone Hcl23$1,527
Prazosin Hcl88$1,379
Clonazepam146$1,345
Bupropion XlBupropion Hcl78$1,234

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Alkermes, Inc.Lybalvi, Aristada$376$121,01463 claims
AbbVieVraylar$31,966$111,27677 claims
Johnson & JohnsonInvega Sustenna$17$103,74633 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$393$43,44214 claims
Indivior Inc.Sublocade$88$22,20811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Asheville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →